UY26908A1 - PROCESS FOR THE MANUFACTURE OF N - ARYL - ANTHRANILIC ACIDS AND THEIR DERIVATIVES - Google Patents

PROCESS FOR THE MANUFACTURE OF N - ARYL - ANTHRANILIC ACIDS AND THEIR DERIVATIVES

Info

Publication number
UY26908A1
UY26908A1 UY26908A UY26908A UY26908A1 UY 26908 A1 UY26908 A1 UY 26908A1 UY 26908 A UY26908 A UY 26908A UY 26908 A UY26908 A UY 26908A UY 26908 A1 UY26908 A1 UY 26908A1
Authority
UY
Uruguay
Prior art keywords
aryl
derivatives
manufacture
anthranilic acids
preparation
Prior art date
Application number
UY26908A
Other languages
Spanish (es)
Inventor
Edward Mark Davis
Javier Magano
Thomas Norman Nanninga
Derick Winkle
Michael Huai Gu Chen
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of UY26908A1 publication Critical patent/UY26908A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Abstract

La presente invención se relaciona con un proceso para la preparación de ácidos N-arilantranílicos, y con un proceso para la preparación de esteres N-antranílicos, amidas, y esteres hidroxamicos.The present invention relates to a process for the preparation of N-arylanthranilic acids, and to a process for the preparation of N-anthranilyl esters, amides, and hydroxamic esters.

UY26908A 2000-08-25 2001-08-24 PROCESS FOR THE MANUFACTURE OF N - ARYL - ANTHRANILIC ACIDS AND THEIR DERIVATIVES UY26908A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22820600P 2000-08-25 2000-08-25

Publications (1)

Publication Number Publication Date
UY26908A1 true UY26908A1 (en) 2001-11-30

Family

ID=22856235

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26908A UY26908A1 (en) 2000-08-25 2001-08-24 PROCESS FOR THE MANUFACTURE OF N - ARYL - ANTHRANILIC ACIDS AND THEIR DERIVATIVES

Country Status (31)

Country Link
EP (1) EP1313694A1 (en)
JP (1) JP2004507518A (en)
KR (1) KR20030059115A (en)
CN (1) CN1458921A (en)
AP (1) AP2001002249A0 (en)
AR (1) AR032175A1 (en)
AU (1) AU2001277044A1 (en)
BG (1) BG107635A (en)
BR (1) BR0113520A (en)
CA (1) CA2420003A1 (en)
CZ (1) CZ2003477A3 (en)
DO (1) DOP2001000238A (en)
EA (1) EA200300187A1 (en)
GT (1) GT200100174A (en)
HN (1) HN2001000216A (en)
HU (1) HUP0300828A2 (en)
IL (1) IL154507A0 (en)
IS (1) IS6724A (en)
MA (1) MA26949A1 (en)
MX (1) MXPA03001654A (en)
NO (1) NO20030844L (en)
PA (1) PA8526501A1 (en)
PE (1) PE20020393A1 (en)
PL (1) PL360699A1 (en)
SK (1) SK2072003A3 (en)
SV (1) SV2002000601A (en)
TN (1) TNSN01127A1 (en)
UY (1) UY26908A1 (en)
WO (1) WO2002018319A1 (en)
YU (1) YU14303A (en)
ZA (1) ZA200301182B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235537B2 (en) 2002-03-13 2007-06-26 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as MEK inhibitors
SG148857A1 (en) 2002-03-13 2009-01-29 Array Biopharma Inc N3 alkylated benzimidazole derivatives as mek inhibitors
US7538120B2 (en) 2003-09-03 2009-05-26 Array Biopharma Inc. Method of treating inflammatory diseases
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
EP1682495A1 (en) 2003-10-21 2006-07-26 Warner-Lambert Company LLC Polymorphic form of n- (r)-2,3-dihydroxy-propoxy -3,4-d ifluoro-2-(2-fluoro-4-iodophenylamino)-benzamide
AU2004293019B2 (en) 2003-11-19 2010-10-28 Array Biopharma Inc. Bicyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
US7517994B2 (en) 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
KR101223914B1 (en) 2003-11-21 2013-01-18 어레이 바이오파마 인크. Akt protein kinase inhibitors
UA89035C2 (en) * 2003-12-03 2009-12-25 Лео Фарма А/С Hydroxamic acid esters and pharmaceutical use thereof
MX2007012659A (en) 2005-04-13 2008-01-11 Astex Therapeutics Ltd Hydroxybenzamide derivatives and their use as inhibitors of hsp90.
TWI441637B (en) 2005-05-18 2014-06-21 Array Biopharma Inc Heterocyclic inhibitors of mek and methods of use thereof
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
DE602007011628D1 (en) 2006-07-06 2011-02-10 Array Biopharma Inc DIHYDROFUROPYRIMIDINES AS ACT PROTEIN KINASE INHIBITORS
WO2008006039A1 (en) 2006-07-06 2008-01-10 Array Biopharma Inc. Dihydrothieno pyrimidines as akt protein kinase inhibitors
MY147628A (en) 2006-07-06 2012-12-31 Array Biopharma Inc Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
JP5721949B2 (en) 2006-10-12 2015-05-20 アステックス、セラピューティックス、リミテッドAstex Therapeutics Limited Compound drug
WO2008044027A2 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical compounds having hsp90 inhibitory or modulating activity
EP2073804B1 (en) 2006-10-12 2017-09-13 Astex Therapeutics Limited Hydroxy-substituted benzoic acid amide compounds for use in the treatment of pain
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
CA2692506C (en) 2007-07-05 2015-11-24 Array Biopharma Inc. Pyrimidyl cyclopentanes as akt protein kinase inhibitors
CN103396409B (en) 2007-07-05 2015-03-11 阵列生物制药公司 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CA2711699A1 (en) 2008-01-09 2009-07-16 Array Biopharma Inc. Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
EP2240455B1 (en) 2008-01-09 2012-12-26 Array Biopharma, Inc. Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CN101985428B (en) * 2009-07-29 2014-02-12 杭州民生药业有限公司 O-anilino benzoic acid derivatives or pharmaceutically acceptable salts thereof as well as preparation method and application thereof
EP2536683A1 (en) * 2010-02-19 2012-12-26 Centre National De La Recherche Scientifique Method for preparing chemical compounds of interest by aromatic nucleophilic substitution
JP2013519715A (en) * 2010-02-19 2013-05-30 センター ナショナル デ ラ リシェルシェ サイエンティフィック Process for the preparation of desired chemical compounds by aromatic nucleophilic substitution of aromatic carboxylic acid derivatives having at least one electron withdrawing group
SG194048A1 (en) 2011-04-01 2013-11-29 Genentech Inc Combinations of akt inhibitor compounds and chemotherapeutic agents, and methods of use
CN103841976A (en) 2011-04-01 2014-06-04 基因泰克公司 Combinations of AKT AND MEK inhibitor compounds, and methods of use
SI2909188T1 (en) * 2012-10-12 2018-07-31 Exelixis, Inc. Novel process for making compounds for use in the treatment of cancer
CN112745237B (en) * 2019-10-29 2023-06-20 中国科学院上海药物研究所 2-arylamine compound and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
US6251943B1 (en) * 1997-02-28 2001-06-26 Warner-Lambert Company Method of treating or preventing septic shock by administering a MEK inhibitor
ES2274572T3 (en) * 1997-07-01 2007-05-16 Warner-Lambert Company Llc ACID DERIVATIVES 2- (4-BROMO- OR 4-IODO-PHENYLAMINE) BENZOIC AND ITS USE AS A MEK INHIBITOR.
WO1999001426A1 (en) * 1997-07-01 1999-01-14 Warner-Lambert Company 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
CA2348236A1 (en) * 1999-01-13 2000-07-20 Stephen Douglas Barrett 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
UA70995C2 (en) * 1999-04-21 2004-11-15 Ворнер-Ламберт Компані a method for making 2-(N-phenylamino)benzoic acid

Also Published As

Publication number Publication date
ZA200301182B (en) 2004-05-12
PL360699A1 (en) 2004-09-20
GT200100174A (en) 2002-07-18
CN1458921A (en) 2003-11-26
IS6724A (en) 2003-02-20
HUP0300828A2 (en) 2003-09-29
HN2001000216A (en) 2002-05-22
PE20020393A1 (en) 2002-05-09
NO20030844D0 (en) 2003-02-24
EP1313694A1 (en) 2003-05-28
CA2420003A1 (en) 2002-03-07
PA8526501A1 (en) 2002-07-30
AU2001277044A1 (en) 2002-03-13
CZ2003477A3 (en) 2003-10-15
MA26949A1 (en) 2004-12-20
YU14303A (en) 2006-08-17
SK2072003A3 (en) 2004-01-08
EA200300187A1 (en) 2003-08-28
BG107635A (en) 2004-09-30
BR0113520A (en) 2003-06-24
SV2002000601A (en) 2002-04-03
DOP2001000238A (en) 2003-01-31
MXPA03001654A (en) 2004-09-10
TNSN01127A1 (en) 2005-11-10
KR20030059115A (en) 2003-07-07
WO2002018319A1 (en) 2002-03-07
JP2004507518A (en) 2004-03-11
IL154507A0 (en) 2003-09-17
NO20030844L (en) 2003-02-25
AR032175A1 (en) 2003-10-29
AP2001002249A0 (en) 2001-09-30

Similar Documents

Publication Publication Date Title
UY26908A1 (en) PROCESS FOR THE MANUFACTURE OF N - ARYL - ANTHRANILIC ACIDS AND THEIR DERIVATIVES
ECSP095220A (en) DERIVATIVES OF N-FENIL-2-PIRIMIDIN-AMINA
HN1999000072A (en) STABILIZED PHARMACEUTICAL PREPARATIONS FOR GABA PENTINA AND PROCESS FOR PREPARING IT.
HN1998000020A (en) ARILSULFONYL HYDROXAMIC ACID DERIVATIVES.
BR0112584A (en) oxygenated esters of 4-iodophenylamino benzhydroxamic acids
BR0115482A (en) Improved sacralose composition and process for its preparation
BR0013885A (en) Perfected tablets
BR9802011A (en) Process for the production of vanillin.
CU22953A3 (en) PROCEDURE FOR THE PREPARATION OF 8-METOXYCHINOLONCARBOXYLIC ACIDS
BR9807936A (en) Immuno-tolerant pharmaceutical preparation of prothrombin complex, process for the production of a preparation, and use of a preparation
DE60038560D1 (en) Process for the fermentative production of L-arginine
CY1105526T1 (en) SYNTHESIS PROCEDURE AND INTERMEDIATES OF PYRIDIN-2-YL-METHYNAMINE
BR0212390A (en) Process for the preparation of cilastatin
NO20023276L (en) Methods of Preparation of Betulinic Acid
DE60129032D1 (en) CREATINESTER PRONUTRIENT COMPOUNDS AND FORMULATIONS
MXPA04000847A (en) Process for the production of beraprost and its salts.
TR200100016T2 (en) Method for the preparation of hydroxymethylthiobutyric acid
AR028078A1 (en) PROCESS FOR THE PRODUCTION OF ENZYME GRRNULES
DE60141311D1 (en) Process for the production of diaphragms
NO20014885L (en) Process for the preparation of an amide compound
ID24138A (en) FERMENTATIVE PRODUCTION PROCESS OF L-AMINO ACIDS
PT1001929E (en) PROCESS FOR THE MANUFACTURE OF 3-CYANO-2,4-DIHALOGENE-5-FLUOROBENZOIC ACIDS
DE50114758D1 (en) PROCESS FOR THE PRODUCTION OF INDOLES
BR0113727A (en) Process for the production of halo-4-phenoxyquinolines
NO20020328L (en) Process for the preparation of 4-cyano-2-aminomethylthiazole

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20141001